Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ancient herb berberine tested to stop heart disease and diabetes in its tracks

NCT ID NCT05749874

First seen Jan 04, 2026 · Last updated Jun 22, 2026 · Updated 23 times

Summary

This large, phase 4 trial is testing whether berberine, a natural compound, can prevent heart disease and diabetes in over 2,000 adults in China who are at high risk. Participants take berberine or a placebo twice a day, along with lifestyle advice. The study looks at blood sugar and other health markers after one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases

    Beijing, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

berberine hydrochloride (a natural compound found in plants like goldenseal and barberry)

What this could lead to

If it works, this could point toward a simple, affordable supplement to help prevent heart disease and diabetes in people at high risk.

What could go wrong

This is a single large trial in China, so results may not apply to other populations. Berberine can cause digestive side effects, and the study is not yet complete.

Conditions

The condition(s) this trial relates to.

atherosclerosis atherosclerotic cardiovascular disease Dyslipidemias hyperlipidemia hypertensive disorder inherited lipid metabolism disorder Obesity, Abdominal prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.